SAB Biotherapeutics, Inc. Stock Performance

Open $2.81	Prev. Close $2.88	Circuit Range N/A
Day Range $2.76 - $2.93	Year Range $2.13 - $5.12	Volume 89,842
Average Traded $2.86

SAB Biotherapeutics, Inc. Share Price Today

As of 9 October 2026, SAB Biotherapeutics, Inc.'s share price is $2.89. The stock opened at $2.81, compared to its previous close of $2.88. During today's trading session, SAB Biotherapeutics, Inc.'s share price traded between $2.76 and $2.93, with an average price of $2.84. Over the past 52 weeks, the stock has recorded a high of $5.12 and a low of $2.13. In terms of performance, SAB Biotherapeutics, Inc.'s share price has declined by 22.52% over the last six months and is down 11.08% on a year-on-year basis.

SAB Biotherapeutics, Inc. Share Price Chart

$2.76$2.93

SAB Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $55.81M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.43	Revenue (TTM) $0.00	Return On Equity (TTM) -18.10%
Profit Margin N/A	Debt to Equity 0.01	Quarterly Earnings Growth YoY -521.16%

SAB Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	$5.34	-$2.85	-$18.87	-$22.49
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-153.37%	-562.11%	-19.18%

SAB Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$23.90	$2.24	$1.32	$0.00
Net Profit	-$18.74	-$42.19	-$34.11	$4.26
Net Profit Margin	-78.41%	-1883.48%	-2584.09%	N/A
Income Change	N/A	-125.13%	19.15%	112.49%

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

SAB Biotherapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$3.13	$2.90	-8.82%
Sep 2026	$3.70	$3.17	-19.01%
Aug 2026	$3.59	$3.92	+10.11%
Jul 2026	$3.90	$3.56	-8.72%
Jun 2026	$3.68	$3.90	+8.48%
May 2026	$3.73	$3.60	-3.62%
Apr 2026	$3.90	$3.73	-2.86%
Mar 2026	$3.98	$3.84	-6.20%
Feb 2026	$4.44	$4.09	-6.53%
Jan 2026	$3.77	$4.38	+17.43%
Dec 2025	$3.95	$3.73	-6.16%
Nov 2025	$3.19	$3.98	+22.31%

SABS Share Price FAQs

What is SAB Biotherapeutics, Inc. share price today?

SAB Biotherapeutics, Inc. share price today is $2.89 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of SAB Biotherapeutics, Inc. stock?

The 52 week high of SAB Biotherapeutics, Inc. stock is $5.12, while the 52 week low is $2.13 as of 9 Oct '26.

What is SABS's market capitalisation today?

SABS market capitalisation is $55.81M as of October 9, 2026, at 6:10 pm IST.

What is SABS's net income for the last quarter?

SABS's net income for the last quarter is -22.49B USD.

What is the 5 year returns of SABS?

The 5 year returns of SABS is -96.35% as on 9 Oct '26.

What is the high & low stock price of SABS today?

SABS stock price hit a high of $2.93 and low of $2.76 as of 9 Oct '26.

Can I buy SABS shares in India?

Yes. You can buy SABS in India by opening an international trading account.